529 related articles for article (PubMed ID: 26724675)
1. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
Sisto M; Barca A; Lofrumento DD; Lisi S
Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
[TBL] [Abstract][Full Text] [Related]
2. A failure of TNFAIP3 negative regulation maintains sustained NF-κB activation in Sjögren's syndrome.
Sisto M; Lisi S; Lofrumento DD; Ingravallo G; Maiorano E; D'Amore M
Histochem Cell Biol; 2011 Jun; 135(6):615-25. PubMed ID: 21604024
[TBL] [Abstract][Full Text] [Related]
3. Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis.
Lippens S; Lefebvre S; Gilbert B; Sze M; Devos M; Verhelst K; Vereecke L; Mc Guire C; Guérin C; Vandenabeele P; Pasparakis M; Mikkola ML; Beyaert R; Declercq W; van Loo G
Cell Death Differ; 2011 Dec; 18(12):1845-53. PubMed ID: 21566665
[TBL] [Abstract][Full Text] [Related]
4. Identification of dkk4 as a target of Eda-A1/Edar pathway reveals an unexpected role of ectodysplasin as inhibitor of Wnt signalling in ectodermal placodes.
Fliniaux I; Mikkola ML; Lefebvre S; Thesleff I
Dev Biol; 2008 Aug; 320(1):60-71. PubMed ID: 18508042
[TBL] [Abstract][Full Text] [Related]
5. X-linked ectodermal dysplasia receptor (XEDAR) gene silencing prevents caspase-3-mediated apoptosis in Sjögren's syndrome.
Sisto M; Lorusso L; Lisi S
Clin Exp Med; 2017 Feb; 17(1):111-119. PubMed ID: 26659383
[TBL] [Abstract][Full Text] [Related]
6. Low Protein A20 in Minor Salivary Glands is Associated with Lymphoma in Primary Sjögren's Syndrome.
Johnsen SJ; Gudlaugsson E; Skaland I; Janssen EA; Jonsson MV; Helgeland L; Berget E; Jonsson R; Omdal R
Scand J Immunol; 2016 Mar; 83(3):181-7. PubMed ID: 26679293
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
Vereecke L; Beyaert R; van Loo G
Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
[TBL] [Abstract][Full Text] [Related]
8. Edar and Troy signalling pathways act redundantly to regulate initiation of hair follicle development.
Pispa J; Pummila M; Barker PA; Thesleff I; Mikkola ML
Hum Mol Genet; 2008 Nov; 17(21):3380-91. PubMed ID: 18689798
[TBL] [Abstract][Full Text] [Related]
9. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
[TBL] [Abstract][Full Text] [Related]
10. Aberrant Low Expression of A20 in Tumor Necrosis Factor-α-stimulated SLE Monocytes Mediates Sustained NF-κB Inflammatory Response.
Shi X; Qian T; Li M; Chen F; Chen Y; Hao F
Immunol Invest; 2015; 44(5):497-508. PubMed ID: 26107748
[TBL] [Abstract][Full Text] [Related]
11. Sjögren's syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB.
Sisto M; Lisi S; Lofrumento DD; D'Amore M; Frassanito MA; Ribatti D
Genes Immun; 2012 Jul; 13(5):411-20. PubMed ID: 22513453
[TBL] [Abstract][Full Text] [Related]
12. Association of genes in the NF-κB pathway with antibody-positive primary Sjögren's syndrome.
Nordmark G; Wang C; Vasaitis L; Eriksson P; Theander E; Kvarnström M; Forsblad-d'Elia H; Jazebi H; Sjöwall C; Reksten TR; Brun JG; Jonsson MV; Johnsen SJ; Wahren-Herlenius M; Omdal R; Jonsson R; Bowman S; Ng WF; Eloranta ML; Syvänen AC;
Scand J Immunol; 2013 Nov; 78(5):447-54. PubMed ID: 23944604
[TBL] [Abstract][Full Text] [Related]
13. Salivary gland expression level of IκBα regulatory protein in Sjögren's syndrome.
Sisto M; Lisi S; Lofrumento DD; Ingravallo G; De Lucro R; D'Amore M
J Mol Histol; 2013 Aug; 44(4):447-54. PubMed ID: 23377923
[TBL] [Abstract][Full Text] [Related]
14. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.
Wertz IE; O'Rourke KM; Zhou H; Eby M; Aravind L; Seshagiri S; Wu P; Wiesmann C; Baker R; Boone DL; Ma A; Koonin EV; Dixit VM
Nature; 2004 Aug; 430(7000):694-9. PubMed ID: 15258597
[TBL] [Abstract][Full Text] [Related]
15. Expression of the nuclear factor-κB inhibitor A20 is altered in the cystic fibrosis epithelium.
Kelly C; Williams MT; Mitchell K; Elborn JS; Ennis M; Schock BC
Eur Respir J; 2013 Jun; 41(6):1315-23. PubMed ID: 23018911
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB transmits Eda A1/EdaR signalling to activate Shh and cyclin D1 expression, and controls post-initiation hair placode down growth.
Schmidt-Ullrich R; Tobin DJ; Lenhard D; Schneider P; Paus R; Scheidereit C
Development; 2006 Mar; 133(6):1045-57. PubMed ID: 16481354
[TBL] [Abstract][Full Text] [Related]
17. DSIF restricts NF-κB signaling by coordinating elongation with mRNA processing of negative feedback genes.
Diamant G; Amir-Zilberstein L; Yamaguchi Y; Handa H; Dikstein R
Cell Rep; 2012 Oct; 2(4):722-31. PubMed ID: 23041311
[TBL] [Abstract][Full Text] [Related]
18. Impaired anti-inflammatory activity of PPARγ in the salivary epithelia of Sjögren's syndrome patients imposed by intrinsic NF-κB activation.
Vakrakou AG; Polyzos A; Kapsogeorgou EK; Thanos D; Manoussakis MN
J Autoimmun; 2018 Jan; 86():62-74. PubMed ID: 29033144
[TBL] [Abstract][Full Text] [Related]
19. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease.
Zhou Q; Wang H; Schwartz DM; Stoffels M; Park YH; Zhang Y; Yang D; Demirkaya E; Takeuchi M; Tsai WL; Lyons JJ; Yu X; Ouyang C; Chen C; Chin DT; Zaal K; Chandrasekharappa SC; Hanson EP; Yu Z; Mullikin JC; Hasni SA; Wertz IE; Ombrello AK; Stone DL; Hoffmann P; Jones A; Barham BK; Leavis HL; van Royen-Kerkof A; Sibley C; Batu ED; Gül A; Siegel RM; Boehm M; Milner JD; Ozen S; Gadina M; Chae J; Laxer RM; Kastner DL; Aksentijevich I
Nat Genet; 2016 Jan; 48(1):67-73. PubMed ID: 26642243
[TBL] [Abstract][Full Text] [Related]
20. Combined expression of A1 and A20 achieves optimal protection of renal proximal tubular epithelial cells.
Kunter U; Daniel S; Arvelo MB; Choi J; Shukri T; Patel VI; Longo CR; Scali ST; Shrikhande G; Rocha E; Czismadia E; Mottley C; Grey ST; Floege J; Ferran C
Kidney Int; 2005 Oct; 68(4):1520-32. PubMed ID: 16164629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
